A carregar...
Synergistic combinations of paclitaxel and withaferin A against human non-small cell lung cancer cells
Platinum-taxane combination chemotherapy still represents the standard of care for advanced non-small cell lung cancer (NSCLC) with no targetable driver mutations. However, the efficacy of these drugs has plateaued at 10–14 months primarily due to dose-limiting toxicity, chemoresistance, and metasta...
Na minha lista:
| Publicado no: | Oncotarget |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Impact Journals LLC
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7185067/ https://ncbi.nlm.nih.gov/pubmed/32362998 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.27519 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|